Genistein and resveratrol, alone and in combination, suppress prostate cancer in SV-40 tag rats

Curt E. Harper, Leah M Cook, Brijesh B. Patel, Jun Wang, Isam A. Eltoum, Ali Arabshahi, Tomoyuki Shirai, Coral A. Lamartiniere

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

BACKGROUND. Chemoprevention utilizing dietary agents is an effective means to slow the development of prostate cancer. We evaluated the potential additive and synergistic effects of genistein and resveratrol for suppressing prostate cancer in the Simian Virus-40 T-antigen (SV-40 Tag) targeted probasin promoter rat model, a transgenic model of spontaneously developing prostate cancer. METHODS. Rats were fed genistein or resveratrol (250 mg/kg AIN-76A diet) alone and in combination, and a low-dose combination (83 mg genistein + 83 mg resveratrol/kg diet). Histopathology and mechanisms of action studies were conducted at 30 and 12 weeks of age, respectively. RESULTS. Genistein, resveratrol, and the high-dose combination treatments suppressed prostate cancer. The low-dose combination did not elicit protection against prostate cancer and was most likely below the effective dose for causing significant histopathological changes. Total genistein and resveratrol concentrations in the blood reached 2,160 and 211 nM, respectively in rats exposed to the single treatments. Polyphenol treatments decreased cell proliferation and insulin-like growth factor-1 (IGF-1) protein expression in the prostate. In addition, genistein as a single agent induced apoptosis and decreased steroid receptor coactivator-3 (SRC-3) in the ventral prostate (VP). CONCLUSIONS. Genistein and resveratrol, alone and in combination, suppress prostate cancer development in the SV-40 Tag model. Regulation of SRC-3 and growth factor signaling proteins are consistent with these nutritional polyphenols reducing cell proliferation and increasing apoptosis in the prostate.

Original languageEnglish (US)
Pages (from-to)1668-1682
Number of pages15
JournalProstate
Volume69
Issue number15
DOIs
StatePublished - Nov 1 2009

Fingerprint

Genistein
Prostatic Neoplasms
Nuclear Receptor Coactivator 3
Prostate
Simian virus 40
Viral Tumor Antigens
Polyphenols
Cell Proliferation
Apoptosis
Diet
Chemoprevention
Somatomedins
resveratrol
Intercellular Signaling Peptides and Proteins
Proteins
Therapeutics

Keywords

  • Chemoprevention
  • Genistein
  • Prostate cancer
  • Resveratrol
  • SV-40 Tag rat

ASJC Scopus subject areas

  • Oncology
  • Urology

Cite this

Harper, C. E., Cook, L. M., Patel, B. B., Wang, J., Eltoum, I. A., Arabshahi, A., ... Lamartiniere, C. A. (2009). Genistein and resveratrol, alone and in combination, suppress prostate cancer in SV-40 tag rats. Prostate, 69(15), 1668-1682. https://doi.org/10.1002/pros.21017

Genistein and resveratrol, alone and in combination, suppress prostate cancer in SV-40 tag rats. / Harper, Curt E.; Cook, Leah M; Patel, Brijesh B.; Wang, Jun; Eltoum, Isam A.; Arabshahi, Ali; Shirai, Tomoyuki; Lamartiniere, Coral A.

In: Prostate, Vol. 69, No. 15, 01.11.2009, p. 1668-1682.

Research output: Contribution to journalArticle

Harper, CE, Cook, LM, Patel, BB, Wang, J, Eltoum, IA, Arabshahi, A, Shirai, T & Lamartiniere, CA 2009, 'Genistein and resveratrol, alone and in combination, suppress prostate cancer in SV-40 tag rats', Prostate, vol. 69, no. 15, pp. 1668-1682. https://doi.org/10.1002/pros.21017
Harper, Curt E. ; Cook, Leah M ; Patel, Brijesh B. ; Wang, Jun ; Eltoum, Isam A. ; Arabshahi, Ali ; Shirai, Tomoyuki ; Lamartiniere, Coral A. / Genistein and resveratrol, alone and in combination, suppress prostate cancer in SV-40 tag rats. In: Prostate. 2009 ; Vol. 69, No. 15. pp. 1668-1682.
@article{f14498ed459544d3994d918ac9f6fbbb,
title = "Genistein and resveratrol, alone and in combination, suppress prostate cancer in SV-40 tag rats",
abstract = "BACKGROUND. Chemoprevention utilizing dietary agents is an effective means to slow the development of prostate cancer. We evaluated the potential additive and synergistic effects of genistein and resveratrol for suppressing prostate cancer in the Simian Virus-40 T-antigen (SV-40 Tag) targeted probasin promoter rat model, a transgenic model of spontaneously developing prostate cancer. METHODS. Rats were fed genistein or resveratrol (250 mg/kg AIN-76A diet) alone and in combination, and a low-dose combination (83 mg genistein + 83 mg resveratrol/kg diet). Histopathology and mechanisms of action studies were conducted at 30 and 12 weeks of age, respectively. RESULTS. Genistein, resveratrol, and the high-dose combination treatments suppressed prostate cancer. The low-dose combination did not elicit protection against prostate cancer and was most likely below the effective dose for causing significant histopathological changes. Total genistein and resveratrol concentrations in the blood reached 2,160 and 211 nM, respectively in rats exposed to the single treatments. Polyphenol treatments decreased cell proliferation and insulin-like growth factor-1 (IGF-1) protein expression in the prostate. In addition, genistein as a single agent induced apoptosis and decreased steroid receptor coactivator-3 (SRC-3) in the ventral prostate (VP). CONCLUSIONS. Genistein and resveratrol, alone and in combination, suppress prostate cancer development in the SV-40 Tag model. Regulation of SRC-3 and growth factor signaling proteins are consistent with these nutritional polyphenols reducing cell proliferation and increasing apoptosis in the prostate.",
keywords = "Chemoprevention, Genistein, Prostate cancer, Resveratrol, SV-40 Tag rat",
author = "Harper, {Curt E.} and Cook, {Leah M} and Patel, {Brijesh B.} and Jun Wang and Eltoum, {Isam A.} and Ali Arabshahi and Tomoyuki Shirai and Lamartiniere, {Coral A.}",
year = "2009",
month = "11",
day = "1",
doi = "10.1002/pros.21017",
language = "English (US)",
volume = "69",
pages = "1668--1682",
journal = "Prostate",
issn = "0270-4137",
publisher = "Wiley-Liss Inc.",
number = "15",

}

TY - JOUR

T1 - Genistein and resveratrol, alone and in combination, suppress prostate cancer in SV-40 tag rats

AU - Harper, Curt E.

AU - Cook, Leah M

AU - Patel, Brijesh B.

AU - Wang, Jun

AU - Eltoum, Isam A.

AU - Arabshahi, Ali

AU - Shirai, Tomoyuki

AU - Lamartiniere, Coral A.

PY - 2009/11/1

Y1 - 2009/11/1

N2 - BACKGROUND. Chemoprevention utilizing dietary agents is an effective means to slow the development of prostate cancer. We evaluated the potential additive and synergistic effects of genistein and resveratrol for suppressing prostate cancer in the Simian Virus-40 T-antigen (SV-40 Tag) targeted probasin promoter rat model, a transgenic model of spontaneously developing prostate cancer. METHODS. Rats were fed genistein or resveratrol (250 mg/kg AIN-76A diet) alone and in combination, and a low-dose combination (83 mg genistein + 83 mg resveratrol/kg diet). Histopathology and mechanisms of action studies were conducted at 30 and 12 weeks of age, respectively. RESULTS. Genistein, resveratrol, and the high-dose combination treatments suppressed prostate cancer. The low-dose combination did not elicit protection against prostate cancer and was most likely below the effective dose for causing significant histopathological changes. Total genistein and resveratrol concentrations in the blood reached 2,160 and 211 nM, respectively in rats exposed to the single treatments. Polyphenol treatments decreased cell proliferation and insulin-like growth factor-1 (IGF-1) protein expression in the prostate. In addition, genistein as a single agent induced apoptosis and decreased steroid receptor coactivator-3 (SRC-3) in the ventral prostate (VP). CONCLUSIONS. Genistein and resveratrol, alone and in combination, suppress prostate cancer development in the SV-40 Tag model. Regulation of SRC-3 and growth factor signaling proteins are consistent with these nutritional polyphenols reducing cell proliferation and increasing apoptosis in the prostate.

AB - BACKGROUND. Chemoprevention utilizing dietary agents is an effective means to slow the development of prostate cancer. We evaluated the potential additive and synergistic effects of genistein and resveratrol for suppressing prostate cancer in the Simian Virus-40 T-antigen (SV-40 Tag) targeted probasin promoter rat model, a transgenic model of spontaneously developing prostate cancer. METHODS. Rats were fed genistein or resveratrol (250 mg/kg AIN-76A diet) alone and in combination, and a low-dose combination (83 mg genistein + 83 mg resveratrol/kg diet). Histopathology and mechanisms of action studies were conducted at 30 and 12 weeks of age, respectively. RESULTS. Genistein, resveratrol, and the high-dose combination treatments suppressed prostate cancer. The low-dose combination did not elicit protection against prostate cancer and was most likely below the effective dose for causing significant histopathological changes. Total genistein and resveratrol concentrations in the blood reached 2,160 and 211 nM, respectively in rats exposed to the single treatments. Polyphenol treatments decreased cell proliferation and insulin-like growth factor-1 (IGF-1) protein expression in the prostate. In addition, genistein as a single agent induced apoptosis and decreased steroid receptor coactivator-3 (SRC-3) in the ventral prostate (VP). CONCLUSIONS. Genistein and resveratrol, alone and in combination, suppress prostate cancer development in the SV-40 Tag model. Regulation of SRC-3 and growth factor signaling proteins are consistent with these nutritional polyphenols reducing cell proliferation and increasing apoptosis in the prostate.

KW - Chemoprevention

KW - Genistein

KW - Prostate cancer

KW - Resveratrol

KW - SV-40 Tag rat

UR - http://www.scopus.com/inward/record.url?scp=70349504367&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349504367&partnerID=8YFLogxK

U2 - 10.1002/pros.21017

DO - 10.1002/pros.21017

M3 - Article

VL - 69

SP - 1668

EP - 1682

JO - Prostate

JF - Prostate

SN - 0270-4137

IS - 15

ER -